Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes

Fig. 1

Probabilistic sensitivity analysis using 1000 simulations of extending the existing program with vaccination of children aged 2–16 years at 50% coverage in the Netherlands over 20 seasons. a The cost-effectiveness plane depicts the incremental costs and QALYs of the individual simulations. The contour line represents the 95% interval of the simulations. The gray line indicates the conventional Dutch cost-effectiveness threshold of €20,000 per QALY gained. b The cost-effectiveness acceptability curve depicts the proportion of cost-effective simulations over a range of cost-effectiveness thresholds

Back to article page